Linde Reports Third-Quarter 2026 Results

Linde reported Q3 2026 sales of $9.404 billion, up 9% year over year. Net income fell 12% to $1.692 billion and diluted EPS declined 11% to $3.66; excluding purchase accounting impacts and specified charges, adjusted net income rose 7% to $2.122 billion and adjusted diluted EPS increased 9% to $4.59.

Analysis

The key signal is the divergence between reported and adjusted earnings: the underlying measure improved, but excluded items are large enough to make the headline result look materially weaker. That supports a cautiously constructive read, not an assumption that all exclusions are economically irrelevant. Verify the nature, cash impact, and recurrence of the purchase-accounting and restructuring charges; repeated “one-time” adjustments would weaken the quality-of-earnings case and could constrain the multiple.

Sales and adjusted EPS grew at similar rates, which does not by itself establish margin expansion: organic volume, price/mix, currency, and acquisition contributions are not provided. The next 1–3 month catalyst is whether management’s outlook and subsequent results confirm durable organic growth and conversion into cash flow. Over 6–18 months, customer project timing and industrial activity could matter more than a single quarter; weaker demand could pressure volumes while contract economics and pricing offer some insulation. Air Products and Air Liquide are relevant competitive read-throughs, but this release alone says nothing about relative share gains.

The contrarian risk is that investors may either dismiss the GAAP decline as accounting noise or overreact to it; the right conclusion depends on cash charges and repeatability, neither supplied here. No valuation, guidance, or price reaction is given, so the release is insufficient to justify chasing LIN or setting a price target.

Key Decisions for Investors

• Keep LIN on a cautiously positive watchlist; do not add solely on the adjusted EPS growth without checking the share-price reaction and valuation context.
• On the next earnings call, verify organic sales growth by volume versus price/mix, currency and acquisition contribution, full-year outlook, and operating cash flow. A guidance cut or weak cash conversion would invalidate the constructive read.
• Track whether excluded charges recur and whether restructuring produces measurable cost savings. Persistent adjustments or cash costs would argue against treating adjusted earnings as the best measure of run-rate performance.
• No immediate pair trade versus Air Products or Air Liquide: consider relative positioning only if subsequent data show a sustained difference in organic growth, margins, or guidance.